Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden
· Delayed Price · Currency is SEK 5.74
-0.76 (-11.69%)
Mar 9, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 315.48 million as of March 9, 2026. Its market cap has increased by 252.54% in one year.
Market Cap
315.48M
Enterprise Value
290.63M
Revenue
10.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.74
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 315.48M, an increase of 157.22%. That is a compound annual growth rate of 22.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 278.59M | 9.96% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Works Technologies AB | 315.18M |
| Lipum AB | 304.40M |
| Ascelia Pharma AB | 366.65M |
| Mendus AB | 258.28M |
| Corline Biomedical AB | 407.26M |
| Oncopeptides AB | 431.42M |
| Intervacc AB | 229.71M |
| Xintela AB | 223.93M |